Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection
Author(s): Allen Loyd V Jr
Issue: Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide
View All Articles in Issue
Abstract: A formulation for preparing Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, panitumumab, cancer, recombinant human monoclonal antibody, epidermal growth factor receptor, antineoplastic agent
Related Categories: CANCER AND AIDS, EAR NOSE THROAT, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS
Download in electronic PDF format for $35